Santen Pharmaceutical Co., Ltd. (TYO:4536)
2,056.00
-7.00 (-0.34%)
Nov 18, 2026, 3:30 PM JST
| Market Cap | 661.58B +29.2% |
| Revenue (ttm) | 297.03B +1.9% |
| Net Income | 38.87B +23.7% |
| EPS | 120.65 +30.1% |
| Shares Out | 321.78M |
| PE Ratio | 17.04 |
| Forward PE | 16.20 |
| Dividend | 42.00 (2.04%) |
| Ex-Dividend Date | Mar 30, 2027 |
| Volume | 1,084,600 |
| Open | 2,037.50 |
| Previous Close | 2,063.00 |
| Day's Range | 2,016.00 - 2,079.50 |
| 52-Week Range | 1,535.00 - 2,254.00 |
| Beta | 0.22 |
| Analysts | Buy |
| Price Target | 2,383.33 (+15.92%) |
| Earnings Date | Nov 5, 2026 |
